리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2025년 11월
페이지 정보:영문 651 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 중심 정맥 카테터(CVC) 시장은 2030년까지 20억 달러 규모에 달할 전망
2024년에 14억 달러로 추정되는 세계의 중심 정맥 카테터(CVC) 시장은 2024-2030년의 분석 기간에 CAGR 6.2%로 성장하며, 2030년까지 20억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석 대상으로 한 부문의 하나인 멀티 루멘 설계는 6.9%의 CAGR을 기록하며, 분석 기간 종료시까지 9억 7,140만 달러에 달할 것으로 예측됩니다. 트리플 루멘 설계 부문의 성장률은 분석 기간에 5.8%의 CAGR로 추정됩니다.
미국 시장은 4억 6,320만 달러로 추정되는 한편, 중국은 7.8%의 CAGR로 성장할 것으로 예측됩니다.
미국에서 중심 정맥 카테터(CVC) 시장은 2024년에 4억 6,320만 달러로 추정되고 있습니다. 세계 2위의 경제 규모를 자랑하는 중국은 2024-2030년의 분석 기간에 CAGR 7.8%로 추이하며, 2030년까지 2억 4,080만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장 분석으로는 일본과 캐나다를 들 수 있으며, 각각 분석 기간 중 5.1%, 5.2%의 CAGR로 성장할 것으로 예측됩니다. 유럽 역내에서는 독일이 약 5.5%의 CAGR로 성장할 것으로 전망되고 있습니다.
세계의 중심 정맥 카테터(CVC) 시장 - 주요 시장 동향과 촉진요인의 개요
중심정맥카테터(CVC)는 약물, 수액, 혈액제제, 경장영양, 혈액투석, 중심정맥압 모니터링에 사용되는 중요한 의료장비입니다. 이 카테터는 보통 경부(내경정맥), 흉부(쇄골하정맥) 또는 살서제(대퇴정맥)의 큰 정맥에 삽입되어 심장 근처의 중심정맥까지 연결됩니다. CVC는 중증 질환을 앓고 있는 환자, 대수술을 받은 환자, 장기적인 정맥내 요법이 필요한 환자 관리에 필수적입니다. 신뢰할 수 있는 장기 정맥내 액세스 포인트를 제공하여 생명을 구하는 치료 및 정확한 순환 역학 평가에 매우 중요합니다.
CVC 기술의 발전으로 안전성, 유효성, 사용 편의성이 크게 향상되었습니다. 현대의 CVC는 감염 위험과 기계적 합병증을 최소화하도록 설계되어 있습니다. 예를 들어 항균 코팅이된 카테터가 개발되어 임상 현장의 주요 관심사인 카테터 관련 혈류감염(CRBSI) 발생률을 낮추는데 기여하고 있습니다. 또한 카테터 재료와 삽입 기술의 발전으로 CVC의 내구성과 생체 적합성이 향상되었습니다. 카테터 삽입시 초음파 가이드의 사용은 삽입과 관련된 합병증을 크게 줄이고 시술의 성공률을 향상시키는 표준적인 방법이 되었습니다. 이러한 기술적, 절차적 혁신을 통해 CVC는 환자와 의료진 모두에게 더욱 안전하고 신뢰할 수 있는 제품으로 거듭났습니다.
중심정맥카테터 시장의 성장은 만성질환 증가, 의료기술의 발전, 수술 건수 증가 등 여러 요인에 의해 주도되고 있습니다. 암, 신장질환, 심부전 등 만성질환이 전 세계에서 증가함에 따라 장기 정맥주사 요법에 대한 수요가 증가하고 있으며, 이에 따라 CVC의 필요성이 증가하고 있습니다. 기술 발전으로 보다 진보되고 안전한 CVC가 개발되어 임상 현장에서의 채택이 확대되고 있습니다. 또한 수술 건수 증가와 집중 치료가 필요한 고령 인구 증가는 시장 성장을 더욱 촉진하고 있습니다. 감염 예방에 대한 관심 증가와 CVC용 항균-항혈전성 코팅의 개발도 시장 확대에 기여하고 있습니다. 이러한 요인에 더해 카테터의 디자인과 기능성을 개선하기 위한 지속적인 연구개발 노력이 더해져 중심정맥카테터 시장의 견고한 성장을 촉진하고 있습니다.
부문:
설계(멀티 루멘, 트리플 루멘, 더블 루멘, 싱글 루멘), 특성(비항균 코팅, 항균 코팅), 용도(경정맥, 대퇴 정맥, 쇄골하 정맥), 최종 용도(병원, 기타 최종 용도)
조사 대상 기업의 예
GE Healthcare
ConMed Corporation
Edwards Lifesciences Corporation
Biosensors International Group Ltd.
ICU Medical, Inc.
FUJIFILM SonoSite, Inc.
Biometrix BV
Bactiguard
Global Medikit Ltd.
Comed B.V.
Foshan Special Medical Co., Ltd.
Guangdong Baihe Medical Technology Co., Ltd.
Biotronix Healthcare, Inc.
Bionic Medizintechnik GmbH
HEKA Srl
AI 통합
검증된 전문가 컨텐츠와 AI 툴을 통해 시장 및 경쟁 정보 분석을 혁신하고 있습니다.
Market Glass, Inc.는 LLM이나 산업별 SLM을 쿼리하는 일반적인 방식에 의존하는 대신, 전 세계 도메인 전문가들이 엄선한 컨텐츠 리포지토리를 구축했습니다. 여기에는 비디오 전사, 블로그, 검색엔진 조사, 그리고 방대한 양의 기업, 제품/서비스, 시장 데이터가 포함됩니다.
관세 영향 계수
Market Glass, Inc.가 본사 소재지, 생산기지, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하는 가운데, 이번 보고서에서는 지역적 시장에 대한 관세의 영향을 반영했습니다. 이러한 복잡하고 다면적인 시장 현실은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 경쟁사에게 다양한 영향을 미치며, 미시적 및 거시적 시장 역학에도 영향을 미칩니다.
목차
제1장 조사 방법
제2장 개요
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
스페인
러시아
기타 유럽
아시아태평양
호주
인도
한국
기타 아시아태평양
라틴아메리카
아르헨티나
브라질
멕시코
기타 라틴아메리카
중동
이란
이스라엘
사우디아라비아
아랍에미리트
기타 중동
아프리카
제4장 경쟁
KSA
영문 목차
영문목차
Global Central Venous Catheters (CVCs) Market to Reach US$2.0 Billion by 2030
The global market for Central Venous Catheters (CVCs) estimated at US$1.4 Billion in the year 2024, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Multi-Lumen Design, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$971.4 Million by the end of the analysis period. Growth in the Triple-Lumen Design segment is estimated at 5.8% CAGR over the analysis period.
The U.S. Market is Estimated at US$463.2 Million While China is Forecast to Grow at 7.8% CAGR
The Central Venous Catheters (CVCs) market in the U.S. is estimated at US$463.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$240.8 Million by the year 2030 trailing a CAGR of 7.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.1% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR.
Global Central Venous Catheters (CVCs) Market - Key Trends & Drivers Summarized
Central Venous Catheters (CVCs) are critical medical devices used for administering medication, fluids, blood products, and parenteral nutrition, as well as for hemodialysis and monitoring central venous pressure. These catheters are inserted into a large vein, typically in the neck (internal jugular vein), chest (subclavian vein), or groin (femoral vein), and threaded through to the central veins near the heart. CVCs are indispensable in the management of patients with severe illnesses, those undergoing major surgeries, and those requiring long-term intravenous therapy. They provide a reliable and long-term intravenous access point, crucial for the delivery of life-saving treatments and accurate hemodynamic assessment.
Advancements in CVC technology have led to significant improvements in their safety, efficacy, and ease of use. Modern CVCs are designed with features that minimize the risk of infection and mechanical complications. Antimicrobial-coated catheters, for instance, have been developed to reduce the incidence of catheter-related bloodstream infections (CRBSIs), a major concern in clinical practice. Additionally, advancements in catheter materials and insertion techniques have enhanced the durability and biocompatibility of CVCs. The use of ultrasound guidance for catheter placement has become standard practice, significantly reducing insertion-related complications and improving the success rate of the procedure. These technological and procedural innovations have made CVCs safer and more reliable for both patients and healthcare providers.
The growth in the central venous catheters market is driven by several factors, including the increasing prevalence of chronic diseases, advancements in medical technology, and the rising number of surgical procedures. The global rise in chronic conditions such as cancer, kidney disease, and heart failure has led to a higher demand for long-term intravenous therapies, consequently boosting the need for CVCs. Technological advancements have resulted in the development of more sophisticated and safer CVCs, which have enhanced their adoption in clinical settings. Furthermore, the growing number of surgical procedures and the expanding geriatric population, who are more likely to require intensive medical care, have further fueled market growth. The increasing focus on infection prevention and the development of antimicrobial and anti-thrombogenic coatings for CVCs are also contributing to the market's expansion. These factors, combined with ongoing research and development efforts to improve catheter design and functionality, are driving the robust growth of the central venous catheters market.
SCOPE OF STUDY:
The report analyzes the Central Venous Catheters (CVCs) market in terms of units by the following Segments, and Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.
Select Competitors (Total 61 Featured) -
GE Healthcare
ConMed Corporation
Edwards Lifesciences Corporation
Biosensors International Group Ltd.
ICU Medical, Inc.
FUJIFILM SonoSite, Inc.
Biometrix BV
Bactiguard
Global Medikit Ltd.
Comed B.V.
Foshan Special Medical Co., Ltd.
Guangdong Baihe Medical Technology Co., Ltd.
Biotronix Healthcare, Inc.
Bionic Medizintechnik GmbH
HEKA Srl
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
Central Venous Catheters (CVCs) - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
Central Venous Catheter (CVC): An Indispensable Medical Device for Healthcare Domain
Contradictions & Complications of CVCs
Types of Central Venous Catheters
Global Market Prospects & Outlook
Global Central Venous Catheters Market by Product Type (in %) for 2020E
Multi-Lumen Design Leads the CVCs Market
Antimicrobial Coated Catheters to Witness High Growth
Hospitals: The Largest End-Use Category
Developing Economies to Spearhead Long-term Growth
Competition
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Incidence of Chronic Diseases Necessitate Central Venous Access, Driving Demand for CVCs
Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
World Diabetes and Population Statistics (2019, 2030 & 2045)
ESRD Prevalence Worldwide: Number of Treated ESRD Patients Per Million Population in Select Countries
Global Annual Medical Cost of CVD in US$ Billion: 2010, 2015, 2020, 2025 and 2030
Aging Population with Higher Susceptibility to Age-related Chronic Conditions to Drive Market Gains
Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
Life Expectancy at Age 60 and 80 Years: (2010-2015), (2020-2025) & (2045-2050)
Use of Central Venous Catheterization for Chemotherapy Administration Boosts Market Growth
Catheters Hold Vital Role in Drugs & Fluid Delivery in Cancer Treatment
Expanding Patient Population Diagnosed with Renal Diseases: Potential Growth for CVCs Market
Global Dialysis Patient Population Breakdown by Geographic Region/Country (2019 and 2024)
Catheter-Related Infections during Hemodialysis Reduce due to Hygiene Procedures
Surgical Procedure Volumes and Shift towards Minimal Invasive Surgeries: Significant Impact on CVCs Market
Global Volume of Surgical Procedures (in Million) by Category
Growth in the Number of Surgeries in the US (2010-2020) and 2001-2010 (in %)
Number of Surgical Procedures (per 100,000 People) in Select Countries
Central Venous Catheters: Playing Critical Role in Parenteral Nutrition
Growing Role of Central Venous Catheters in Drug Administration
Rising Use of Central Venous Catheters in ICU Settings
Growing Adoption of Antimicrobial Impregnated Catheters
Technologically Advanced CVCs Promise Better Outcomes for Interventional Procedures
3M Korea's All-in-One PICC/CVC Securing System
Clear Correlation between CVD Risk and Central Venous Catheter Insertion Calls for Minimization of Catheter Use
Consistent Rise in Healthcare Spending Worldwide to Drive Market Opportunities
World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021 and 2023
Elderly Healthcare Expenditure as a % of GDP in the US, Europe and Japan for 1970, 2010 and 2050
Challenges Facing Central Venous Catheters Market
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 2: World Historic Review for Central Venous Catheters (CVCs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 3: World 15-Year Perspective for Central Venous Catheters (CVCs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Multi-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 5: World Historic Review for Multi-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 6: World 15-Year Perspective for Multi-Lumen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Triple-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 8: World Historic Review for Triple-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 9: World 15-Year Perspective for Triple-Lumen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Double-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 11: World Historic Review for Double-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 12: World 15-Year Perspective for Double-Lumen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Single-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 14: World Historic Review for Single-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 15: World 15-Year Perspective for Single-Lumen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Non-Antimicrobial Coated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 17: World Historic Review for Non-Antimicrobial Coated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 18: World 15-Year Perspective for Non-Antimicrobial Coated by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Antimicrobial Coated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 20: World Historic Review for Antimicrobial Coated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 21: World 15-Year Perspective for Antimicrobial Coated by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Jugular Vein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 23: World Historic Review for Jugular Vein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 24: World 15-Year Perspective for Jugular Vein by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 25: World Recent Past, Current & Future Analysis for Femoral Vein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 26: World Historic Review for Femoral Vein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 27: World 15-Year Perspective for Femoral Vein by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 28: World Recent Past, Current & Future Analysis for Subclavian Vein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 29: World Historic Review for Subclavian Vein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 30: World 15-Year Perspective for Subclavian Vein by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 31: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 32: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 33: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 34: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 35: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 36: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 37: World Central Venous Catheters (CVCs) Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
III. MARKET ANALYSIS
UNITED STATES
Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 38: USA Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 39: USA Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 40: USA 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2015, 2025 & 2030
TABLE 41: USA Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 42: USA Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 43: USA 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2015, 2025 & 2030
TABLE 44: USA Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 45: USA Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 46: USA 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2015, 2025 & 2030
TABLE 47: USA Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 48: USA Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 49: USA 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
CANADA
TABLE 50: Canada Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 51: Canada Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 52: Canada 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2015, 2025 & 2030
TABLE 53: Canada Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 54: Canada Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 55: Canada 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2015, 2025 & 2030
TABLE 56: Canada Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 57: Canada Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 58: Canada 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2015, 2025 & 2030
TABLE 59: Canada Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 60: Canada Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 61: Canada 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
JAPAN
Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 62: Japan Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 63: Japan Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 64: Japan 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2015, 2025 & 2030
TABLE 65: Japan Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 66: Japan Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 67: Japan 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2015, 2025 & 2030
TABLE 68: Japan Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 69: Japan Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 70: Japan 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2015, 2025 & 2030
TABLE 71: Japan Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 72: Japan Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 73: Japan 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
CHINA
Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 74: China Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 75: China Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 76: China 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2015, 2025 & 2030
TABLE 77: China Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 78: China Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 79: China 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2015, 2025 & 2030
TABLE 80: China Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 81: China Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 82: China 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2015, 2025 & 2030
TABLE 83: China Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 84: China Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 85: China 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
EUROPE
Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 86: Europe Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 87: Europe Historic Review for Central Venous Catheters (CVCs) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 88: Europe 15-Year Perspective for Central Venous Catheters (CVCs) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
TABLE 89: Europe Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 90: Europe Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 91: Europe 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2015, 2025 & 2030
TABLE 92: Europe Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 93: Europe Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 94: Europe 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2015, 2025 & 2030
TABLE 95: Europe Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 96: Europe Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 97: Europe 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2015, 2025 & 2030
TABLE 98: Europe Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 99: Europe Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 100: Europe 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
FRANCE
Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 101: France Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 102: France Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 103: France 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2015, 2025 & 2030
TABLE 104: France Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 105: France Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 106: France 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2015, 2025 & 2030
TABLE 107: France Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 108: France Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 109: France 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2015, 2025 & 2030
TABLE 110: France Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 111: France Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 112: France 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
GERMANY
Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 113: Germany Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 114: Germany Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 115: Germany 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2015, 2025 & 2030
TABLE 116: Germany Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 117: Germany Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 118: Germany 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2015, 2025 & 2030
TABLE 119: Germany Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 120: Germany Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 121: Germany 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2015, 2025 & 2030
TABLE 122: Germany Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 123: Germany Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 124: Germany 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
ITALY
TABLE 125: Italy Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 126: Italy Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 127: Italy 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2015, 2025 & 2030
TABLE 128: Italy Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 129: Italy Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 130: Italy 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2015, 2025 & 2030
TABLE 131: Italy Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 132: Italy Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 133: Italy 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2015, 2025 & 2030
TABLE 134: Italy Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 135: Italy Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 136: Italy 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
UNITED KINGDOM
Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 137: UK Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 138: UK Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 139: UK 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2015, 2025 & 2030
TABLE 140: UK Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 141: UK Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 142: UK 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2015, 2025 & 2030
TABLE 143: UK Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 144: UK Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 145: UK 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2015, 2025 & 2030
TABLE 146: UK Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 147: UK Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 148: UK 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
SPAIN
TABLE 149: Spain Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 150: Spain Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 151: Spain 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2015, 2025 & 2030
TABLE 152: Spain Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 153: Spain Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 154: Spain 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2015, 2025 & 2030
TABLE 155: Spain Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 156: Spain Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 157: Spain 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2015, 2025 & 2030
TABLE 158: Spain Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 159: Spain Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 160: Spain 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
RUSSIA
TABLE 161: Russia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 162: Russia Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 163: Russia 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2015, 2025 & 2030
TABLE 164: Russia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 165: Russia Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 166: Russia 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2015, 2025 & 2030
TABLE 167: Russia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 168: Russia Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 169: Russia 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2015, 2025 & 2030
TABLE 170: Russia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 171: Russia Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 172: Russia 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
REST OF EUROPE
TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 174: Rest of Europe Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 175: Rest of Europe 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2015, 2025 & 2030
TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 177: Rest of Europe Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 178: Rest of Europe 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2015, 2025 & 2030
TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 180: Rest of Europe Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 181: Rest of Europe 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2015, 2025 & 2030
TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 183: Rest of Europe Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 184: Rest of Europe 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
ASIA-PACIFIC
Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 186: Asia-Pacific Historic Review for Central Venous Catheters (CVCs) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 187: Asia-Pacific 15-Year Perspective for Central Venous Catheters (CVCs) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 189: Asia-Pacific Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 190: Asia-Pacific 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2015, 2025 & 2030
TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 192: Asia-Pacific Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 193: Asia-Pacific 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2015, 2025 & 2030
TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 195: Asia-Pacific Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 196: Asia-Pacific 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2015, 2025 & 2030
TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 198: Asia-Pacific Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 199: Asia-Pacific 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
AUSTRALIA
Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
TABLE 200: Australia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 201: Australia Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 202: Australia 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2015, 2025 & 2030
TABLE 203: Australia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 204: Australia Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 205: Australia 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2015, 2025 & 2030
TABLE 206: Australia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 207: Australia Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 208: Australia 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2015, 2025 & 2030
TABLE 209: Australia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 210: Australia Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 211: Australia 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
INDIA
Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
TABLE 212: India Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 213: India Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 214: India 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2015, 2025 & 2030
TABLE 215: India Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 216: India Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 217: India 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2015, 2025 & 2030
TABLE 218: India Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 219: India Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 220: India 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2015, 2025 & 2030
TABLE 221: India Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 222: India Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 223: India 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
SOUTH KOREA
TABLE 224: South Korea Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 225: South Korea Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 226: South Korea 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2015, 2025 & 2030
TABLE 227: South Korea Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 228: South Korea Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 229: South Korea 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2015, 2025 & 2030
TABLE 230: South Korea Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 231: South Korea Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 232: South Korea 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2015, 2025 & 2030
TABLE 233: South Korea Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 234: South Korea Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 235: South Korea 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
REST OF ASIA-PACIFIC
TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 237: Rest of Asia-Pacific Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 238: Rest of Asia-Pacific 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2015, 2025 & 2030
TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 240: Rest of Asia-Pacific Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2015, 2025 & 2030
TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 243: Rest of Asia-Pacific Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2015, 2025 & 2030
TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 246: Rest of Asia-Pacific Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
LATIN AMERICA
Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
TABLE 248: Latin America Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 249: Latin America Historic Review for Central Venous Catheters (CVCs) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 250: Latin America 15-Year Perspective for Central Venous Catheters (CVCs) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
TABLE 251: Latin America Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 252: Latin America Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 253: Latin America 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2015, 2025 & 2030
TABLE 254: Latin America Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 255: Latin America Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 256: Latin America 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2015, 2025 & 2030
TABLE 257: Latin America Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 258: Latin America Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 259: Latin America 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2015, 2025 & 2030
TABLE 260: Latin America Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 261: Latin America Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 262: Latin America 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
ARGENTINA
TABLE 263: Argentina Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 264: Argentina Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 265: Argentina 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2015, 2025 & 2030
TABLE 266: Argentina Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 267: Argentina Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 268: Argentina 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2015, 2025 & 2030
TABLE 269: Argentina Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 270: Argentina Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 271: Argentina 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2015, 2025 & 2030
TABLE 272: Argentina Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 273: Argentina Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 274: Argentina 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
BRAZIL
TABLE 275: Brazil Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 276: Brazil Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 277: Brazil 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2015, 2025 & 2030
TABLE 278: Brazil Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 279: Brazil Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 280: Brazil 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2015, 2025 & 2030
TABLE 281: Brazil Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 282: Brazil Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 283: Brazil 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2015, 2025 & 2030
TABLE 284: Brazil Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 285: Brazil Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 286: Brazil 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
MEXICO
TABLE 287: Mexico Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 288: Mexico Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 289: Mexico 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2015, 2025 & 2030
TABLE 290: Mexico Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 291: Mexico Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 292: Mexico 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2015, 2025 & 2030
TABLE 293: Mexico Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 294: Mexico Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 295: Mexico 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2015, 2025 & 2030
TABLE 296: Mexico Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 297: Mexico Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 298: Mexico 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
REST OF LATIN AMERICA
TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 300: Rest of Latin America Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 301: Rest of Latin America 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2015, 2025 & 2030
TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 303: Rest of Latin America Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 304: Rest of Latin America 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2015, 2025 & 2030
TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 306: Rest of Latin America Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 307: Rest of Latin America 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2015, 2025 & 2030
TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 309: Rest of Latin America Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 310: Rest of Latin America 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
MIDDLE EAST
Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
TABLE 311: Middle East Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 312: Middle East Historic Review for Central Venous Catheters (CVCs) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 313: Middle East 15-Year Perspective for Central Venous Catheters (CVCs) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
TABLE 314: Middle East Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 315: Middle East Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 316: Middle East 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2015, 2025 & 2030
TABLE 317: Middle East Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 318: Middle East Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 319: Middle East 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2015, 2025 & 2030
TABLE 320: Middle East Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 321: Middle East Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 322: Middle East 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2015, 2025 & 2030
TABLE 323: Middle East Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 324: Middle East Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 325: Middle East 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
IRAN
TABLE 326: Iran Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 327: Iran Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 328: Iran 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2015, 2025 & 2030
TABLE 329: Iran Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 330: Iran Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 331: Iran 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2015, 2025 & 2030
TABLE 332: Iran Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 333: Iran Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 334: Iran 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2015, 2025 & 2030
TABLE 335: Iran Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 336: Iran Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 337: Iran 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
ISRAEL
TABLE 338: Israel Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 339: Israel Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 340: Israel 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2015, 2025 & 2030
TABLE 341: Israel Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 342: Israel Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 343: Israel 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2015, 2025 & 2030
TABLE 344: Israel Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 345: Israel Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 346: Israel 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2015, 2025 & 2030
TABLE 347: Israel Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 348: Israel Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 349: Israel 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
SAUDI ARABIA
TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 351: Saudi Arabia Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 352: Saudi Arabia 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2015, 2025 & 2030
TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 354: Saudi Arabia Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 355: Saudi Arabia 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2015, 2025 & 2030
TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 357: Saudi Arabia Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 358: Saudi Arabia 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2015, 2025 & 2030
TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 360: Saudi Arabia Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 361: Saudi Arabia 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
UNITED ARAB EMIRATES
TABLE 362: UAE Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 363: UAE Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 364: UAE 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2015, 2025 & 2030
TABLE 365: UAE Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 366: UAE Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 367: UAE 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2015, 2025 & 2030
TABLE 368: UAE Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 369: UAE Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 370: UAE 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2015, 2025 & 2030
TABLE 371: UAE Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 372: UAE Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 373: UAE 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
REST OF MIDDLE EAST
TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 375: Rest of Middle East Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 376: Rest of Middle East 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2015, 2025 & 2030
TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 378: Rest of Middle East Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 379: Rest of Middle East 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2015, 2025 & 2030
TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 381: Rest of Middle East Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 382: Rest of Middle East 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2015, 2025 & 2030
TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 384: Rest of Middle East Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 385: Rest of Middle East 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
AFRICA
Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
TABLE 386: Africa Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 387: Africa Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 388: Africa 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2015, 2025 & 2030
TABLE 389: Africa Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 390: Africa Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 391: Africa 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2015, 2025 & 2030
TABLE 392: Africa Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 393: Africa Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 394: Africa 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2015, 2025 & 2030
TABLE 395: Africa Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 396: Africa Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 397: Africa 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2015, 2025 & 2030